4 recruiting. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 4 |
| Phase 2 | 1 | Recruiting 1 |
Follow Stomatitis: new trials by email Literature Review of Stomatitis trials Research Report on Stomatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis alpha lipoic acid 600 mg twice daily, Placebo Tablet - Colorectal Cancer | Phase 2 / Phase 3 | Recruiting | Ain Shams University | 50 | 2026-07-27 | 2026-07-30 |
| A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer. BupiZenge 25 mg, Lidocaine viscous 2% - Head & Neck Cancer, Oral Mucositis | Phase 3 | Recruiting | OncoZenge AB | 150 | 2026-07-07 | 2026-10-27 |
| Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT Double low-power laser therapy simultaneous applicated - Hematopoietic Stem Cell Transplantation, Low-Level Light Therapy | Phase 3 | Recruiting | Instituto Nacional de Cancer, Brazil | 84 | 2023-08-01 | 2023-10-06 |
| Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults Low-Level Laser Therapy, Placebo - Mucositis Oral | Phase 3 | Recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 315 | 2018-08-29 | 2026-02-06 |
Colorectal Neoplasms (1) · Head and Neck Neoplasms (1) · Inflammation (1)
Mouth Diseases (4) · Stomatognathic Diseases (4) · Neoplasms (2) · Neoplasms by Site (2) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Rectal Diseases (1)
Low-Level Light Therapy (1) · Thioctic Acid (1)
Ain Shams University (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Instituto Nacional de Cancer, Brazil (1) · OncoZenge AB (1)
Brazil (1) · Denmark (1) · Egypt (1) · France (1) · Germany (1) · Norway (1) · Sweden (1)
2025 (1)